![John Donatello Manieri](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Donatello Manieri
Keine laufenden Positionen mehr
Karriereverlauf von John Donatello Manieri
Ehemalige bekannte Positionen von John Donatello Manieri
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Bellevue Asset Management AG
![]() Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Portfolio Manager-Aktien | 01.01.2015 | - |
COSMO PHARMACEUTICALS N.V. | Investor Relations Kontakt | 01.05.2017 | - |
Adamant Biomedical Investments AG
![]() Adamant Biomedical Investments AG Investment ManagersFinance Adamant Biomedical Investments AG (Adamant) is the subsidiary of Bellevue Group AG (SW: BBN) in Switzerland. The firm was established in 2000 as a joint venture between Swiss Life Asset Management and three partners, formerly with the Bellevue Group (which comprises BB Biotech and BB Medtech). The firm's name derives from the Greek word for 'uncut diamond' and refers to their philosophy of uncovering hidden value. Located in Zurich, Adamant is a biomedical sector specialist. The firm manages sector-specific portfolios domiciled in Luxembourg. Their clients are institutions. | Analyst-Equity | 01.05.2001 | - |
Portfolio Manager-Aktien | 05.10.2011 | - |
Ausbildung von John Donatello Manieri
The University of Chicago Booth School of Business | Masters Business Admin |
Statistik
International
Schweiz | 3 |
Irland | 2 |
Vereinigte Staaten | 2 |
Operativ
Portfolio Manager-Equities | 2 |
Analyst-Equity | 1 |
Investor Relations Contact | 1 |
Sektoral
Finance | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
COSMO PHARMACEUTICALS N.V. | Health Technology |
Private Unternehmen | 2 |
---|---|
Adamant Biomedical Investments AG
![]() Adamant Biomedical Investments AG Investment ManagersFinance Adamant Biomedical Investments AG (Adamant) is the subsidiary of Bellevue Group AG (SW: BBN) in Switzerland. The firm was established in 2000 as a joint venture between Swiss Life Asset Management and three partners, formerly with the Bellevue Group (which comprises BB Biotech and BB Medtech). The firm's name derives from the Greek word for 'uncut diamond' and refers to their philosophy of uncovering hidden value. Located in Zurich, Adamant is a biomedical sector specialist. The firm manages sector-specific portfolios domiciled in Luxembourg. Their clients are institutions. | Finance |
Bellevue Asset Management AG
![]() Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Finance |
- Börse
- Insiders
- John Donatello Manieri
- Erfahrung